Search hospitals > California > Whittier

Innovative Clinical Research Institute

Claim this profile
Whittier, California 90603
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Lymphoma
Conducts research for Cancer
123 reported clinical trials
9 medical researchers
Photo of Innovative Clinical Research Institute in WhittierPhoto of Innovative Clinical Research Institute in WhittierPhoto of Innovative Clinical Research Institute in Whittier

Summary

Innovative Clinical Research Institute is a medical facility located in Whittier, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Lymphoma, Cancer and other specialties. Innovative Clinical Research Institute is involved with conducting 123 clinical trials across 105 conditions. There are 9 research doctors associated with this hospital, such as Omkar S Marathe, Richy Agajanian, MD, Amitabha Mazumder, and Paul La Porte.

Area of expertise

1Non-Small Cell Lung Cancer
Global Leader
Innovative Clinical Research Institute has run 27 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive
2Lung Cancer
Global Leader
Innovative Clinical Research Institute has run 23 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive

Top PIs

Clinical Trials running at Innovative Clinical Research Institute

Non-Small Cell Lung Cancer
Lymphoma
Lung Cancer
Breast Cancer
Solid Tumors
Head and Neck Cancers
Follicular Lymphoma
Tumors
Polycythemia Vera
Primary Myelofibrosis
Image of trial facility.

Inupadenant + Chemotherapy

for Non-Small Cell Lung Cancer

Part 1 of the study determines the optimal dose of inupadenant to be given in combination with carboplatin and pemetrexed to patients that progressed after receiving specific first line treatments for Stage 3 or metastatic non-small cell lung cancer. Part 2 compares the efficacy of inupadenant to placebo when both are combined with carboplatin and pemetrexed for patients that progressed after receiving the same first line treatments for Stage 3 or metastatic non-small cell lung cancer.
Recruiting2 awards Phase 27 criteria
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative to pembrolizumab (PEMBRO) in combination with chemotherapy on progression-free survival (PFS) and overall survival (OS) in patients with untreated metastatic non-small cell lung cancer with no actionable genomic alteration.
Recruiting2 awards Phase 38 criteria
Image of trial facility.

HBI-2438

for Cancer with KRAS G12C Mutation

A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of HBI-2438 and characterize its pharmacokinetic profile.
Recruiting1 award Phase 16 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Innovative Clinical Research Institute?
Innovative Clinical Research Institute is a medical facility located in Whittier, California. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Lymphoma, Cancer and other specialties. Innovative Clinical Research Institute is involved with conducting 123 clinical trials across 105 conditions. There are 9 research doctors associated with this hospital, such as Omkar S Marathe, Richy Agajanian, MD, Amitabha Mazumder, and Paul La Porte.